Triptolide induces apoptosis through the SERCA 3 upregulation in PC12 cells

General Physiology and Biophysics

Volumn 33, Issue 1, 2014, Pages 137-144

  Krizanova, Olga ^a   Markova, Jana ^a   Pacak, Karel ^b   Skultety, Ludovit ^c   Soltysova, Andrea ^a   Hudecova, Sona ^a  

^a INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

Apoptosis; Calcium transport; SERCA 3; Triptolide

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS; CALCIUM; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DITERPENES; EPOXY COMPOUNDS; GENE EXPRESSION REGULATION, NEOPLASTIC; MACROCYCLIC COMPOUNDS; MICROSCOPY, FLUORESCENCE; NF-KAPPA B; NOREPINEPHRINE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXAZOLES; PC12 CELLS; PHENANTHRENES; PHOSPHATIDYLINOSITOL 3-KINASES; RATS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; THAPSIGARGIN;

EID: 84894211498     PISSN: 02315882     EISSN: 13384325     Source Type: Journal    
DOI: 10.4149/gpb_2014004     Document Type: Article

References (27)

1. Antonoff M. B., Chugh R., Skube S. J., Dudeja V., Borja-Cacho D., Clawson K. A., Vickers S. M., Saluja A. K. (2010): Role of Hsp-70 in triptolide-mediated cell death of neuroblastoma. J. Surg. Res. 163, 72-78 http://dx.doi.org/10.1016/j.jss.2010.04.047
2. Arbabian A., Brouland J. P., Apati A., Pászty K., Hegedus L., Enyedi A., Chomienne C., Papp B. (2013): Modulation of endoplasmic reticulum calcium pump expression during lung cancer cell differentiation. FEBS J. 280, 5408-5418 http://dx.doi.org/10.1111/febs.12064
3. Arbabian A., Brouland J. P., Gelebart P., Kovacs T., Bobe R., Enouf J., Papp B. (2011): Endoplasmic reticulum calcium pumps and cancer. Biofactors 37, 139-149 http://dx.doi.org/10.1002/biof.142
4. Cai Y. Y., Lin W. P., Li A. P, Xu J. Y. (2013): Combined effects of curcumin and triptolide on an ovarian cancer cell line. Asian. Pac. J. Cancer. Prev. 14, 4267-4271 http://dx.doi.org/10.7314/APJCP.2013.14.7.4267
5. Clawson K. A., Borja-Cacho D., Antonoff M. B., Saluja A. K., Vickers S. M. (2010): Triptolide and TRAIL Combination Enhances Apoptosis in Cholangiocarcinoma. J. Surg. Res. 163, 244-249 http://dx.doi.org/10.1016/j.jss. 2010.03.067
6. Gonias S., Goldsby R., Matthay K. K., Hawkins R., Price D., Huberty J., Damon L., Linker C., Sznewajs A., Shiboski S., Fitzgerald P. (2009): Phase II study of high-dose [131I] metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma. J. Clin. Oncol. 27, 4162-4168 http://dx.doi.org/10.1200/JCO.2008.21.3496
7. Grunwald F., Ezziddin S. (2010): 131I-metaiodobenzylguanidine therapy of neuroblastoma and other neuroendocrine tumors. Semin. Nucl. Med. 40, 153-163 http://dx.doi.org/10.1053/j.semnuclmed.2009.11.004
8. Hanson C. J., Bootman M. D., Roderick H. L. (2004): Cell signalling: IP3 receptors channel calcium into cell death. Curr. Biol. 14, 933-935 http://dx.doi.org/10.1016/j.cub.2004.10.019
9. Huang W., He T., Chai C., Yang Y., Zheng Y., Zhou P., Qiao X., Zhang B., Liu Z., Wang J., Shi C., Lei L., Gao K., Li H., Zhong S., Yao L., Huang M. E., Lei M. (2012): Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression. PLoS One 7, e37693 http://dx.doi.org/10.1371/journal.pone.0037693
10. Karin M. (2006): Nuclear factor-kappaB in cancer development and progression. Nature, 441, 431-436 http://dx.doi.org/10.1038/nature04870
11. Krosch T. C., Sangwan V., Banerjee S., Mujumdar N., Dudeja V., Saluja A. K., Vickers S. M. (2013): Triptolide-mediated cell death in neuroblastoma occurs by both apoptosis and autophagy pathways and results in inhibition of nuclear factor-kappa B activity. Am. J. Surg. 205, 387-396 http://dx.doi.org/10.1016/j. amjsurg.2013.01.008
12. Ku C. M., Lin J. Y. (2013): Anti-inflammatory effects of 27 selected terpenoid compounds tested through modulating Th1/Th2 cytokine secretion profiles using murine primary splenocytes. Food. Chem. 141, 1104-1113 http://dx.doi.org/10.1016/j.foodchem.2013.04.044
13. Kupchan S. M., Schubert R. M. (1974): Selective alkylation: a biomimetic reaction of the antileukemic triptolides? Science 185, 791-793 http://dx.doi.org/10.1126/science.185.4153.791
14. Lee H. F., Lee T. S., Kou Y. R. (2012): Anti-inflammatory and neuroprotective effects of triptolide on traumatic brain injury in rats. Respir. Physio. Neurobiol. 182, 1-8 http://dx.doi.org/10.1016/j.resp.2012.01.016
15. Lencesova L., Hudecova S., Csaderova L., Markova J., Soltysova A., Pastorek M., Sedlak J., Wood M. E., Whiteman M., Ondrias K., Krizanova O. (2013): Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. Acta Physiol. (Oxford) 208, 350-361 http://dx.doi.org/10.1111/apha.12105
16. Lencesova L., Krizanova O. (2012): IP(3) receptors, stress and apoptosis. Gen. Physiol. Biophys. 31, 119-130 http://dx.doi.org/10.4149/gpb-2012-014
17. Leuenroth S. J., Crews C. M. (2005): Studies on calcium dependence reveal multiple modes of action for triptolide. Chem. Biol. 12, 1259-1268 http://dx.doi.org/10.1016/j.chembiol.2005.09.009
18. Leuenroth S. J., Okuhara D., Shotwell J. D., Markowitz G. S., Yu Z., Somlo S., Crews C. M. (2007): Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proc. Natl. Acad. Sci. U.S.A. 104, 4389-4394 http://dx.doi.org/10.1073/pnas.0700499104
19. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. (1951): Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275
20. Lytton J., Westlin M., Hanley M. R. (1991): Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J. Biol. Chem. 266, 17067-17071
21. MacKenzie T. N., Mujumdar N., Banerjee S., Sangwan V., Sarver A., Vickers S., Subramanian S., Saluja A. K. (2013): Triptolide induces the expression of miR-142-3p: a negative regulator of heat shock protein 70 and pancreatic cancer cell proliferation. Mol. Cancer Ther. 12, 1266-1275 http://dx.doi.org/10.1158/ 1535-7163.MCT-12-1231
22. Pacak K., Sirova M., Giubellino A., Lencesova L., Csaderova L., Laukova M., Hudecova S., Krizanova O. (2012): NF-κB inhibition significantly upregulates the norepinephrine transporter system, causes apoptosis in pheochromocytoma cell lines and prevents metastasis in an animal model. Int. J. Cancer 131, 2445-2455 http://dx.doi.org/10.1002/ijc.27524
23. Rogers T. B., Inesi G., Wade R., Lederer W. J. (1995): Use of thapsigargin to study Ca2+ homeostasis in cardiac cells. Biosci. Rep. 15, 341-349 http://dx.doi.org/10.1007/BF01788366
24. Wang Z., Jin H., Xu R., Mei Q., Fan D. (2009): Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression. Exp. Mol. Med. 41, 717-727 http://dx.doi.org/10.3858/emm.2009.41. 10.078
25. Wen H. L., Liang Z. S., Zhang R., Yang K. (2013): Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy. Cardiovasc. Diabetol. 12, 50 http://dx.doi.org/10.1186/ 1475-2840-12-50
26. Yang S., Chen J., Guo Z., Xu X. M., Wang L., Pei X. F., Yang J., Underhill C. B., Zhang L. (2003): Triptolide inhibits the growth and metastasis of solid tumors. Mol. Cancer Ther. 2, 65-72
27. Yu D. Q., Zhang D. M., Wang H. B., Liang X. T. (1992): Structure modification of triptolide, a diterpenoid from Tripterygium wilfordii. Yao Xue Xue Bao. 27, 830-836 (in Chinese)